Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 165

Suse corrals Rancher Labs

Tesltra Ventures is exiting Kubernetes management platform developer Rancher in an acquisition reportedly sized at between $600m and $700m.

Jul 9, 2020

LeddarTech adds Vayavision in acquisition deal

LG and Mitsubishi UFJ Capital have exited the driver assistance technology developer in a purchase of undisclosed size by LeddarTech.

Jul 8, 2020

Cambricon cashes $368m in IPO

CAS-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

Jul 8, 2020

AlloVir approaches public markets

Baylor College spinout AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.

Jul 8, 2020

Ant Financial anticipates $200bn IPO valuation

Alibaba's financial services spinoff is reportedly lining up an offering this year that would also represent an exit for China Life and China Post.

Jul 8, 2020

Cambricon cashes $368m in initial public offering

Lenovo, iFlytek, Alibaba and Tuling Century-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

Jul 8, 2020

Ucommune opens its doors to reverse merger

The co-working space provider, which counts a slew of corporates among its investors, will list on Nasdaq by merging with a SPAC in a deal jointly valuing them at $769m.

Jul 8, 2020

Efort looks to house $118m in IPO

The robotics technology provider, a spinoff from automotive manufacturer Chery, plans to float in a Shanghai offering that will also allow Midea to exit.

Jul 8, 2020

AlloVir approaches public markets

Gilead-backed AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.

Jul 8, 2020

Nurix picks Nasdaq for $100m IPO filing

UC Berkeley and UC San Francisco-linked small molecule cancer drug developer Nurix Therapeutics has filed for an IPO on the Nasdaq Global Market.

Jul 7, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here